Hyperbilirubinemia in pediatrics: Evaluation and care

Pramodha Muniyappa1, Darah Kelley2

  • 1Division of Pediatric Gastroenterology and Nutrition, Dayton Children's Hospital, Dayton, OH 45404, United States.

Insights

This review covers the evaluation and diagnosis of hyperbilirubinemia in children, from newborns to older kids. It uses the latest guidelines from pediatric gastroenterology societies to differentiate causes from benign to severe.

Area of Science:

  • Pediatric Gastroenterology
  • Neonatology
  • Clinical Diagnostics

Background:

  • Hyperbilirubinemia is a frequent lab finding in pediatric patients, particularly neonates.
  • It encompasses a spectrum of conditions, ranging from harmless physiological variations to critical systemic diseases.
  • Accurate diagnosis is crucial for appropriate management and preventing complications.

Purpose of the Study:

  • To provide a comprehensive overview of hyperbilirubinemia evaluation in infants and children.
  • To outline differential diagnoses for pediatric hyperbilirubinemia.
  • To present the latest evidence-based guidelines for managing this condition.

Main Methods:

  • Literature review of recent guidelines from major pediatric gastroenterology organizations.
  • Synthesis of diagnostic approaches for hyperbilirubinemia in different age groups.
  • Analysis of differential diagnoses based on clinical presentation and laboratory findings.

Main Results:

  • Established guidelines offer a structured approach to evaluating pediatric hyperbilirubinemia.
  • Key factors in diagnosis include age of onset, bilirubin levels, and clinical signs.
  • A systematic workup helps distinguish benign causes from serious underlying pathologies.

Conclusions:

  • A thorough evaluation based on current guidelines is essential for diagnosing pediatric hyperbilirubinemia.
  • Timely and accurate diagnosis facilitates appropriate treatment and improves patient outcomes.
  • This review serves as a practical resource for clinicians managing hyperbilirubinemia in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
110
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
104
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
174
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
151